Clinical Trial Update: Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates the combination of lenvatinib and everolimus in patients with advanced, unresectable carcinoid tumors and related digestive syst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Digestive System Neuroendocrine Neoplasm
• Multiple Endocrine Neoplasia Type
• Neuroendocrine Neoplasm
• Unresectable Carcinoid Tumor

Drugs mentioned

• Afinitor (everolimus)
• LENVIMA (lenvatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Carcinoid Tumor, Digestive System Neuroendocrine Neoplasm | Phase 2 | Status: ACTIVE_NOT_RECRUITING